<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01853215</url>
  </required_header>
  <id_info>
    <org_study_id>2013-04</org_study_id>
    <nct_id>NCT01853215</nct_id>
  </id_info>
  <brief_title>Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum</brief_title>
  <official_title>A Follow-Up Volunteer Study Evaluating Intraosseous Vascular Access Infusion in the Sternum Using the EZ-IO T.A.L.O.N.Intraosseous System.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vidacare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vidacare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to evaluate intraosseous vascular access through the sternum.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the presence or absence of extravasation when using
      the T.A.L.O.N. Intraosseous System to establish sternal intraosseous infusion. This study
      will also evaluate the user preference feedback received from the device operators about the
      ease of use and level of satisfaction with the device. Lastly, this study will evaluate the
      infusion flow rates obtained when using intraosseous infusion in the sternum.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrences of Extravasation During Infusion</measure>
    <time_frame>during 12 minutes of infusion</time_frame>
    <description>The number of occurrences of extravasation with intraosseous infusion as evidenced by contrast injection into the intraosseous catheter, visualized under fluoroscopic imaging.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stability of Locator</measure>
    <time_frame>During insertion of the intraosseous needle set</time_frame>
    <description>Operator's perceived stability of the sternal locator once placed on the subject.
1 to 5 scale was used with 1=Poor; 2=Fair; 3=Good; 4=Very good; 5=Excellent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stability of Catheter Hub</measure>
    <time_frame>During insertion of the intraosseous needle set</time_frame>
    <description>Ability to stabilize the catheter hub and rotate the stylet for removal. 1 to 5 scale was used with 1=Very difficult; 2-Difficult; 3=Neutral; 4=Easy; 5=Very easy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adhesion Strips</measure>
    <time_frame>During insertion of the intraosseous needle set</time_frame>
    <description>Perceived effeciveness of the device adhesion strips after application. A 1- 5 scale was used with 1=Poor; 2=Fair; 3=Good; $=Very good; 5=Excellent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gravity Flow Rates</measure>
    <time_frame>during the 12 minute infusion time frame</time_frame>
    <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a gravity infusion (no Pressure).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>100mmHg Infusion Flow Rates</measure>
    <time_frame>during the 12 minute infusion time frame</time_frame>
    <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 100 mmHg infusion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>200mmHg Infusion Flow Rates</measure>
    <time_frame>during the 12 minute infusion time frame</time_frame>
    <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 200 mmHg infusion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>300mmHg Infusion Flow Rates</measure>
    <time_frame>during the 12 minute infusion time frame</time_frame>
    <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 300 mmHg infusion.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Intraosseous Vascular Access</condition>
  <arm_group>
    <arm_group_label>Sternal intraosseous vascular access</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sternal intraosseous vascular access using T.A.L.O.N. Intraosseous System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>T.A.L.O.N. Intraosseous System</intervention_name>
    <description>intraosseous catheter for use in the sternum</description>
    <arm_group_label>Sternal intraosseous vascular access</arm_group_label>
    <other_name>EZ-IO TALON</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  21 years of age or older;

          -  healthy adult subjects

        Exclusion Criteria:

          -  Weight &lt; 45kg;

          -  BMI greater or equal to 30 with absence of adequate landmarks or too much overlaying
             tissue, as determined by the PI;

          -  Imprisoned subjects;

          -  pregnant subjects;

          -  prior sternotomy;

          -  cognitively impaired subjects;

          -  fracture in target bone, or significant trauma to the site;

          -  excessive tissue and/or absence of adequate anatomical landmarks in target bone;

          -  infection in target area;

          -  IO insertion in past 48 hours or other significant orthopedic procedure in target
             bone;

          -  current use of anti-coagulants;

          -  previous adverse reaction to Lidocaine;

          -  current cardiac condition requiring pacemaker or anti-arrhythmic drugs

          -  previous adverse reaction to contrast dye

          -  Allergy to any food and drug

          -  History of impaired renal function

          -  History of impaired hepatic function

          -  History of cardiac disease

          -  History of pheochromocytoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larry J Miller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vidacare Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bulverde-Spring Branch EMS</name>
      <address>
        <city>Spring Branch</city>
        <state>Texas</state>
        <zip>78070</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2013</study_first_submitted>
  <study_first_submitted_qc>May 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2013</study_first_posted>
  <results_first_submitted>June 6, 2013</results_first_submitted>
  <results_first_submitted_qc>August 9, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 18, 2013</results_first_posted>
  <last_update_submitted>August 9, 2013</last_update_submitted>
  <last_update_submitted_qc>August 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sternal intraosseous infusion study</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Healthy adults aged 21 years and older were recruited to participate in the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Sternal Intraosseous Vascular Access</title>
          <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System: intraosseous catheter for use in the sternum</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sternal Intraosseous Vascular Access</title>
          <description>sternal intraosseous vascular access using T.A.L.O.N. Sternal Manual Intraosseous Needle set
T.A.L.O.N. Sternal Manual Intraosseous Needle set : intraosseous catheter for use in the sternum</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.4" spread="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Occurrences of Extravasation During Infusion</title>
        <description>The number of occurrences of extravasation with intraosseous infusion as evidenced by contrast injection into the intraosseous catheter, visualized under fluoroscopic imaging.</description>
        <time_frame>during 12 minutes of infusion</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Sternal Intraosseous Vascular Access</title>
            <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System : intraosseous catheter for use in the sternum</description>
          </group>
        </group_list>
        <measure>
          <title>Occurrences of Extravasation During Infusion</title>
          <description>The number of occurrences of extravasation with intraosseous infusion as evidenced by contrast injection into the intraosseous catheter, visualized under fluoroscopic imaging.</description>
          <population>Per protocol</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stability of Locator</title>
        <description>Operator's perceived stability of the sternal locator once placed on the subject.
1 to 5 scale was used with 1=Poor; 2=Fair; 3=Good; 4=Very good; 5=Excellent.</description>
        <time_frame>During insertion of the intraosseous needle set</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Sternal Intraosseous Vascular Access</title>
            <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System: intraosseous catheter for use in the sternum</description>
          </group>
        </group_list>
        <measure>
          <title>Stability of Locator</title>
          <description>Operator's perceived stability of the sternal locator once placed on the subject.
1 to 5 scale was used with 1=Poor; 2=Fair; 3=Good; 4=Very good; 5=Excellent.</description>
          <population>Per protocol</population>
          <units>Likert scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.04" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stability of Catheter Hub</title>
        <description>Ability to stabilize the catheter hub and rotate the stylet for removal. 1 to 5 scale was used with 1=Very difficult; 2-Difficult; 3=Neutral; 4=Easy; 5=Very easy.</description>
        <time_frame>During insertion of the intraosseous needle set</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sternal Intraosseous Vascular Access</title>
            <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System: intraosseous catheter for use in the sternum</description>
          </group>
        </group_list>
        <measure>
          <title>Stability of Catheter Hub</title>
          <description>Ability to stabilize the catheter hub and rotate the stylet for removal. 1 to 5 scale was used with 1=Very difficult; 2-Difficult; 3=Neutral; 4=Easy; 5=Very easy.</description>
          <units>Likert scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.35" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adhesion Strips</title>
        <description>Perceived effeciveness of the device adhesion strips after application. A 1- 5 scale was used with 1=Poor; 2=Fair; 3=Good; $=Very good; 5=Excellent.</description>
        <time_frame>During insertion of the intraosseous needle set</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sternal Intraosseous Vascular Access</title>
            <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System : intraosseous catheter for use in the sternum</description>
          </group>
        </group_list>
        <measure>
          <title>Adhesion Strips</title>
          <description>Perceived effeciveness of the device adhesion strips after application. A 1- 5 scale was used with 1=Poor; 2=Fair; 3=Good; $=Very good; 5=Excellent.</description>
          <units>Likert scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.83" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gravity Flow Rates</title>
        <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a gravity infusion (no Pressure).</description>
        <time_frame>during the 12 minute infusion time frame</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Sternal Intraosseous Vascular Access</title>
            <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System: intraosseous catheter for use in the sternum</description>
          </group>
        </group_list>
        <measure>
          <title>Gravity Flow Rates</title>
          <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a gravity infusion (no Pressure).</description>
          <population>Per protocol</population>
          <units>milliliters per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1130.44" spread="691.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>100mmHg Infusion Flow Rates</title>
        <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 100 mmHg infusion.</description>
        <time_frame>during the 12 minute infusion time frame</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Sternal Intraosseous Vascular Access</title>
            <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System: intraosseous catheter for use in the sternum</description>
          </group>
        </group_list>
        <measure>
          <title>100mmHg Infusion Flow Rates</title>
          <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 100 mmHg infusion.</description>
          <population>Per protocol</population>
          <units>milliliters per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3373.91" spread="1370.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>200mmHg Infusion Flow Rates</title>
        <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 200 mmHg infusion.</description>
        <time_frame>during the 12 minute infusion time frame</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Sternal Intraosseous Vascular Access</title>
            <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System: intraosseous catheter for use in the sternum</description>
          </group>
        </group_list>
        <measure>
          <title>200mmHg Infusion Flow Rates</title>
          <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 200 mmHg infusion.</description>
          <population>Per protocol</population>
          <units>milliliters per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4619.05" spread="1785.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>300mmHg Infusion Flow Rates</title>
        <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 300 mmHg infusion.</description>
        <time_frame>during the 12 minute infusion time frame</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Sternal Intraosseous Vascular Access</title>
            <description>sternal intraosseous vascular access using T.A.L.O.N.
T.A.L.O.N. Intraosseous System: intraosseous catheter for use in the sternum</description>
          </group>
        </group_list>
        <measure>
          <title>300mmHg Infusion Flow Rates</title>
          <description>Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 300 mmHg infusion.</description>
          <population>Per protocol</population>
          <units>milliliters per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5327.27" spread="1724.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sternal Intraosseous Vascular Access</title>
          <description>sternal intraosseous vascular access using T.A.L.O.N. Sternal Manual Intraosseous Needle set
T.A.L.O.N. Sternal Manual Intraosseous Needle set : intraosseous catheter for use in the sternum</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Larry J. Miller, MD</name_or_title>
      <organization>Vidacare Corporation</organization>
      <phone>210-375-8500</phone>
      <email>larry.miller@vidacare.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

